Welcome to the MPH Mittelständische Pharma Holding AG

The MPH Mittelständische Pharma Holding AG is a stock exchange listed company whose focus is on the growth segments in the pharmaceutical industry.

The subsidiary HAEMATO PHARM AG is engaged in patent free and patent protected pharmaceutical substances. Core area are therapies in oncology, HIV, rheumatism, neurology and cardiovascular diseases.

Another subsidiary, HAEMATO Vet GmbH, serves its customers with veterinary pharmaceutical and medical products as well as animal complement feed. Additional strategic business segments are to be developed based on challenges created on the pharmaceutical market. They will be developed to new core competences in additional group companies.

Q3 results 2011